Search
Sloan Kettering Institute investigators have learned how Hedgehog proteins, which are important in both development and cancer, are assembled.
The discovery of a molecular process that slows down cell division could provide new understanding about how some cancers develop.
Scientists have generated a compound that could potentially be used to create a new type of pain medication that may prevent the side effects of currently available painkillers.
Twelve students successfully defended their dissertations and received their PhD degrees at Commencement on May 19.
Researchers have produced a fully synthetic, functional version of erythropoietin, the hormone that controls production of red blood cells.
With the resurgence of interest in cancer metabolism, researchers are coming to realize that there is more to a cell’s biochemistry than once thought.
Memorial Sloan Kettering researchers have discovered a way that cancer cells may be able to exchange information by establishing long bridges between cells called tunneling nanotubes.
As part of a commitment to seek new and better treatments for cancer patients, Memorial Sloan Kettering Cancer Center and Bristol-Myers Squibb are collaborating to bring a potential new cancer drug called iso-fludelone, or KOS-1803, into clinical trials.
On April 27 and 28 at Mohonk Mountain House in New Paltz, New York, Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK) held its fifth biennial retreat for members of the school’s community.
The Metastasis Research Center has brought together 27 Memorial Sloan Kettering laboratories to facilitate research on metastasis and its treatment.